Company news
enGene Therapeutics Inc. news in 2026
enGene Therapeutics Inc.'s news releases, calls and decks from 2026, newest first.
enGene to Initiate a BLA Submission for Detalimogene by Year End and Reports New Data from LEGEND Trial Pivotal Cohort 1 in BCG-Unresponsive NMIBC
November 11, 2026
enGene Appoints Key Executives in Anticipation of Upcoming Regulatory and Commercial Milestones
November 11, 2026
enGene to Participate in Upcoming Investor Conferences
November 6, 2026
enGene to Host KOL Webinar on October 15, 2026
October 13, 2026
enGene Reports Third Quarter 2026 Financial Results and Provides Business Update
September 8, 2026
enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones
July 16, 2026
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
June 15, 2026
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
May 7, 2026
enGene Announces Name Change to enGene Therapeutics Inc.
April 6, 2026
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
March 8, 2026
Amendment to Annual Report (Form 10-K/A)
February 19, 2026
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 20, 2026
Decks in 2026
- Investor Presentation (November 2026)
Investor deck · 41 slides · Nov 12, 2026
- Technical Presentation (November 2026)
Technical · 35 slides · Nov 12, 2026
- Technical Presentation (October 2026)
Technical · 35 slides · Oct 15, 2026
- Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
- Investor Day (August 2026)
Investor day · 23 slides · Aug 11, 2026
- Investor Presentation (July 2026)
Investor deck · 35 slides · Jul 17, 2026
- Corporate Update (May 2026)
Corporate update · 20 slides · May 7, 2026
- American Urological Association Annual Meeting 2026
Conference · 12 slides · May 2026